O’Brien, Charles P.

DSM-5 criteria for substance use disorders: recommendations and rationale

Hasin, D. S., O’Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., et al. (2013) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesGambling Behavior and Treatments

Cited by 1,622

Limbic Activation During Cue-Induced Cocaine Craving

Childress, A. R., Mozley, P. D., McElgin, W., Fitzgerald, J., Reivich, M., & O’Brien, C. P. (1999) · American Journal of Psychiatry

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 1,513

Anticraving Medications for Relapse Prevention: A Possible New Class of Psychoactive Medications

O’Brien, C. P. (2005) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 405

Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial

Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., Dackis, C., & O’Brien, C. P. (2006) · Archives of General Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 348

Extended-release naltrexone to prevent opioid relapse in criminal justice offenders

Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A., Wilson, D., McDonald, R., Rotrosen, J., Gourevitch, M. N., et al. (2016) · New England Journal of Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 315

Effect of naltrexone on alcohol “high” in alcoholics

Volpicelli, J. R., Watson, N. T., King, A. C., Sherman, C. E., & O’Brien, C. P. (1995) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 308

Issues for DSM-V: Should obesity be included as a brain disorder?

Volkow, N. D., & O’Brien, C. P. (2007) · American Journal of Psychiatry

Eating Disorders and BehaviorsMental Health and Psychiatry

Cited by 271

Concurrent Naltrexone and Prolonged Exposure Therapy for Patients With Comorbid Alcohol Dependence and PTSD: A Randomized Clinical Trial

Foa, E. B., Yusko, D. A., McLean, C. P., Suvak, M. K., Bux, D. A., Oslin, D., O’Brien, C. P., Imms, P., Riggs, D. S., & Volpicelli, J. (2013) · JAMA

Posttraumatic Stress Disorder ResearchSubstance Abuse Treatment and Outcomes

Cited by 267

A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence

Kampman, K. M., Pettinati, H. M., Lynch, K. G., Spratt, K., Wierzbicki, M. R., & O’Brien, C. P. (2013) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 115

A VBM study demonstrating ‘apparent’' effects of a single dose of medication on T1-weighted MRIs

Franklin, T. R., Wang, Z., Shin, J., Jagannathan, K., Suh, J. J., Detre, J. A., O’Brien, C. P., & Childress, A. R. (2013) · Brain Structure and Function

Advanced MRI Techniques and ApplicationsAdvanced Neuroimaging Techniques and Applications

Cited by 57

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction

Clarke, T. ‐., Ambrose‐Lanci, L., Ferraro, T. N., Berrettini, W. H., Kampman, K. M., Dackis, C. A., Pettinati, H. M., O’Brien, C. P., Oslin, D. W., & Lohoff, F. W. (2012) · Genes, Brain and Behavior

Neurotransmitter Receptor Influence on BehaviorGenetic Associations and Epidemiology

Cited by 55

A Randomized Trial of Oral Naltrexone for Treating Opioid‐Dependent Offenders

Coviello, D. M., Cornish, J. W., Lynch, K. G., Alterman, A. I., & O’Brien, C. P. (2010) · The American Journal on Addictions

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 50